Analyst Price Targets — CYRX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 5, 2025 2:29 pm | — | UBS | $12.50 | $8.75 | TheFly | Cryoport price target raised to $12.50 from $11 at UBS |
| September 18, 2025 11:33 am | — | BTIG | $15.00 | $8.90 | TheFly | Cryoport price target raised to $15 from $10 at BTIG |
| April 1, 2025 11:47 am | — | UBS | $11.00 | $6.09 | TheFly | Cryoport price target raised to $11 from $10 at UBS |
| March 24, 2025 10:26 am | — | UBS | $10.00 | $7.10 | TheFly | Cryoport upgraded to Buy from Neutral at UBS |
| December 19, 2024 12:06 pm | Subbu Nambi | Guggenheim | $11.00 | $7.62 | TheFly | Cryoport initiated with a Buy at Guggenheim |
| August 7, 2024 6:26 am | Matthew Stanton | Jefferies | $8.00 | $7.79 | TheFly | Cryoport downgraded to Hold at Jefferies on diminished growth outlook |
| July 31, 2024 3:29 am | Yuan Zhi | B.Riley Financial | $15.00 | $9.05 | StreetInsider | B.Riley Upgrades CryoPort (CYRX) to Buy |
| May 3, 2024 3:46 am | Yuan Zhi | B.Riley Financial | $19.00 | $15.95 | StreetInsider | B.Riley Downgrades CryoPort (CYRX) to Neutral |
| April 4, 2024 4:09 am | Matthew Stanton | Jefferies | $21.00 | $18.34 | StreetInsider | Jefferies Assumes CryoPort (CYRX) at Buy, 'Thesis Refresh' |
| March 13, 2024 6:36 am | David Saxon | Needham | $18.00 | $14.36 | StreetInsider | CryoPort (CYRX) PT Lowered to $18 at Needham |
Latest News for CYRX
NASHVILLE, Tenn., Feb. 17, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the fourth quarter and year ended December 31, 2025 on Tuesday, March 3, 2026 after U.S. markets close.
Self-Sustaining Fusion® 800 Series Cryogenic Freezer Delivers High-Capacity Storage, Flexibility, and Cost Benefits in Limited Space Environments NASHVILLE, Tenn., Feb. 11, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of temperature-controlled supply chain solutions for the life sciences, today announced the launch of the MVE Fusion® 800 Series, the…
Cryoport, Inc. launched the Fusion 800 Series, a compact cryogenic storage system that eliminates the need for continuous liquid nitrogen. Revenue grew 15% in Q3, and fiscal 2025 revenue guidance was raised to $170-174 million.
CryoPort (NASDAQ: CYRX - Get Free Report) and Royal Mail (OTCMKTS:ROYMY - Get Free Report) are both transportation companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation. Institutional and Insider Ownership 92.9% of CryoPort shares are
Shares of CryoPort, Inc. (NASDAQ: CYRX - Get Free Report) have earned an average rating of "Moderate Buy" from the eleven ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CYRX.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.